CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
Hong Jun Kim, Suk-young Lee, Dae Sik Kim, Eun Joo Kang, Jung Sun Kim, Yoon Ji Choi, Sang Cheul Oh, Jae Hong Seo, Jun Suk Kim
    DOI: https://doi.org/10.3904/kjim.2018.076

Excel Download

753PVenous thromboembolism in Asian patients with pancreatic cancer who underwent palliative chemotherapy: Low prevalence, but a poor prognostic factor for early onset
Annals of Oncology. 2018;29(suppl_8):   Crossref logo
Link1

Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival
Cancer Chemotherapy and Pharmacology. 2014;75(3):457-464   Crossref logo
Link1 Link2 Link3

204PPrognostic impact of progression type by RECIST criteria in patients with metastatic pancreatic cancer who received first-line gemcitabine-based chemotherapy
Annals of Oncology. 2018;29(suppl_9):   Crossref logo
Link1

Molecular Markers for Treatment Response and Toxicity of Gemcitabine
Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019;175-195   Crossref logo
Link1 Link2

Serum levels of LDH, CEA, and CA19-9 have prognostic roles on survival in patients with metastatic pancreatic cancer receiving gemcitabine-based chemotherapy
Cancer Chemotherapy and Pharmacology. 2014;73(6):1163-1171   Crossref logo
Link1 Link2 Link3

Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy
Cancer. 2012;119(2):285-292   Crossref logo
Link1 Link2 Link3

5-Fluorouracil/Leucovorin Combined with Irinotecan and Oxaliplatin (FOLFIRINOX) as Second-Line Chemotherapy in Patients with Advanced Pancreatic Cancer Who Have Progressed on Gemcitabine-Based Therapy
Chemotherapy. 2013;59(4):273-279   Crossref logo
Link1 Link2

Pancreatic Cancer Resistance to Gemcitabine
Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019;45-56   Crossref logo
Link1 Link2

Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy
Cancer Medicine. 2015;4(7):989-994   Crossref logo
Link1

2375 Prognostic index based on the phase III study of gemcitabine plus S-1, S-1 alone or gemcitabine alone in patients with advanced pancreatic cancer (GEST study)
European Journal of Cancer. 2015;51:S462   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Korean J Intern Med has participated in CrossRef Text and Data Mining service since August 31, 2015.